Emerging Antifungal Targets and Strategies
Open accessThe DOI matches its Crossref record; 152 of the 154 references it cites were found in a registry or an index.
Abstract
Despite abundant research in the field of antifungal drug discovery, fungal infections remain a significant healthcare burden. There is an emerging need for the development of novel antifungals since those currently available are limited and do not completely provide safe and secure protection. Since the current knowledge regarding the physiology of fungal cells and the infection mechanisms is greater than ever, we have the opportunity to use this for the development of novel generations of antifungals. In this review, we selected and summarized recent studies describing agents employing different antifungal mechanisms. These mechanisms include interference with fungal resistance, including impact on the efflux pumps and heat shock protein 90. Additionally, interference with virulence factors, such as biofilms and hyphae; the impact on fungal enzymes, metabolism, mitochondria, and cell wall; and antifungal vaccines are explored. The agents investigated belong to different classes of natural or synthetic molecules with significant attention given also to plant extracts. The efficacy of these antifungals has been studied mainly in vitro with some in vivo, and clinical studies are needed. Nevertheless, there is a large quantity of products employing novel antifungal mechanisms that can be further explored for the development of new generation of antifungals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It was synthesized based on ToAP2 and exhibited antifungal activity against Sporothrix globosa with good serum stability and low toxicity (81).”
From Recent Progress in Research on Mitochondrion-Targeted Antifungal Drugs: a Review (2023) · cites this paper as [81]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Cell wall of fungus, being the outermost component of the cell, facilitates the initial physical interaction between microorganisms and their environment, including the host [19].”
From Mitochondrial anchor protein Num11 is key to pathogenicity of Candida albicans by affecting mitochondrial function and cell wall masking (2025) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resistance of Candida to azoles and echinocandins worldwide
Pristov, K. E., & Ghannoum, M. A. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.03.028 · Cited by 706 · cited 1×
“The exact mechanism of resistance is linked with the mutation of two regions of the FKS1p subunit of β-(1,3) d-glucan synthase, which subsequently leads to the substitution of serine 645 for proline, phenylalanine, and tyrosine and changes the echinocandins target site [40].”
BackgroundStone, N. R. H., Bicanic, T., Salim, R., & Hope, W. (2016) · Drugs · doi:10.1007/s40265-016-0538-7 · Cited by 537 · cited 2×
“However, due to recorded significant dose-limiting toxicity of this formulation, mainly nephrotoxicity and infusion-related reactions, less toxic formulations were developed [27].”
BackgroundAmphotericin forms an extramembranous and fungicidal sterol sponge
Anderson, T. M., Clay, M. C., Cioffi, A. G., Diaz, K. A., Hisao, G. S., Tuttle, M. D., Nieuwkoop, A. J., Comellas, G., Maryum, N., Wang, S., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1496 · Cited by 528 · cited 2×
“It is proposed that extraction of the essential cell lipid underlies the antifungal action of this compound [26].”
BackgroundCampoy, S., & Adrio, J. L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.019 · Cited by 511
Emerging Threats in Antifungal-Resistant Fungal Pathogens
Sanglard, D. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00011 · Cited by 416 · cited 1×
“Mechanisms of antifungal resistance include decrease of effective drug concentration, drug target alterations, and metabolic bypasses [48].”
BackgroundSpampinato, C., & Leonardi, D. (2013) · BioMed Research International · doi:10.1155/2013/204237 · Cited by 411 · cited 1×
“Additionally, point mutations in ERG3 can inactivate C5 sterol desaturase leading to alterations in the ergosterol synthetic pathway and inducing azole resistance [15].”
BackgroundCavassin, F. B., Baú-Carneiro, J. L., Vilas-Boas, R. R., & Queiroz-Telles, F. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00382-7 · Cited by 382
Lemke, A., Kiderlen, A. F., & Kayser, O. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-1955-9 · Cited by 305
Candida Species Biofilms’ Antifungal Resistance
Silva, S., Rodrigues, C., Araújo, D., Rodrigues, M., & Henriques, M. (2017) · Journal of Fungi · doi:10.3390/jof3010008 · Cited by 302
Contribution of Clinically Derived Mutations in ERG11 to Azole Resistance in Candida albicans
Flowers, S. A., Colón, B., Whaley, S. G., Schuler, M. A., & Rogers, P. D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03470-14 · Cited by 294 · cited 1×
“Mutations in ERG11 are frequent among azole-resistant clinical fungal strains [103].”
Background
Cited by
Items 101–174 of 174
Kukavica, B. M., Škondrić, S., Gašić, U. M., Stojković, D. S., Nikolić, F., Trifković, T., Nakarada, Đ. J., Mojović, M., & Mišić, D. M. (2025) · Biochemical Systematics and Ecology · doi:10.1016/j.bse.2025.105123 · Cited by 2
Self-citationFathima, J., & Chatterjee, P. (2025) · Journal of Hazardous Toxic and Radioactive Waste · doi:10.1061/jhtrbp.hzeng-1573 · Cited by 2
Bordoloi, S., Prasad, R., Lakshmi, V., Chandramohanadas, R., Natarajan, K., & Sathi, S. N. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.02.569695 · Cited by 2
Waykar, R. G., & Kumarapillai, S. (2024) · International Journal of Pharmaceutical Quality Assurance · doi:10.25258/ijpqa.15.3.33 · Cited by 3
“35 For instance, riboflavin (RF) has been revealed in the direction of disrupting membrane and cell wall integrity in C. albicans , indicating that the RF metabolic pathway could be a potential drug target.”
REVIEW AND STUDY OF METAL COMPLEXES WITH ANTIFUNGAL POTENTIAL AGAINST Candida albicans STRAINS
Silva, S. S. D., & dos Santos, E. R. (2024) · SOUTHERN JOURNAL OF SCIENCES · doi:10.48141/2764-5959.05.v32.n38.2024_rocha_pgs_37_55.pdf · Cited by 1
Breaking the Mold: Advances and Hurdles in Antifungal Resistance Management for Dermatophytes
Alnsour, Z. R., AlNsour, M., Alnsour, A. R., Massadeh, M. M., Alzoubi, K. H., & Masadeh, M. M. (2025) · Current Clinical Pharmacology · doi:10.2174/0127724328328331241217194034 · Cited by 1
Ivanov, M., Stojković, D. S., & Sokóvić, M. (2025) · Springer eBooks · doi:10.1007/978-981-96-1305-2_7 · Cited by 2
Self-citationSasmita, M., Marwoto, P., Nugroho, S. E., & Sumarni, W. (2025) · Jurnal Penelitian Pendidikan IPA · doi:10.29303/jppipa.v11i5.10075 · Cited by 2
He, R., Xie, J., Hao, J., Wang, B., Jin, C., & Fang, W. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.03143-25 · Cited by 1
Álvarez, N. H., Stegmayer, M. I., Micheloud, N., Buyatti, M., & Derita, M. (2026) · Revista Fitos · doi:10.32712/2446-4775.2026.1977 · Cited by 1
Xu, X., Jiang, B., Xiong, J., Jiang, Y., & Lu, H. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128864 · Cited by 1
Deptuła, P., Chmielewska-Deptuła, S. J., Spałek, J., Kaliniak, S., Okła, S., & Bucki, R. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119705 · Cited by 1
Anbazhagan, A., & Venugopal, S. (2022) · Asian Journal of Chemistry · doi:10.14233/ajchem.2022.23865 · Cited by 1
Research Progress on Fungal Infections in Patients with End-Stage Liver Disease
余, 敏. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.142338 · Cited by 1
Antimicrobial and antibiofilm activities of Inga cylindrica trypsin inhibitor
Pereira, A. P. R., Jacobowski, A. C., Sardi, J. D. C. O., Almeida, C. V., Almeida, L. H. D. O., Silva, M. A. A. G., & Macedo, M. L. R. (2024) · Brazilian Journal of Biology · doi:10.1590/1519-6984.283106 · Cited by 1
Kurian, T., & Sebastian, R. (2024) · Journal of Pharmaceutical Research · doi:10.18579/jopcr/v23.3.101 · Cited by 1
Sustainable Goals for Achieving Disease Control in Livestock and Animal Industry
(2023) · International Journal of Agriculture and Biosciences · doi:10.47278/book.oht/2023.27
dos Santos, A. L. S., Ramos, L. S., de Mello, T. P., & Branquinha, M. H. (2023) · Future Microbiology · doi:10.2217/fmb-2023-0105
СУЧАСНІ УЯВЛЕННЯ ПРО ЕТІОЛОГІЮ ТА ПАТОГЕНЕЗ ДЕРМАТОМІКОЗІВ
Москалюк, В. Д., & Кравчук, И. И. (2023) · Інфекційні хвороби · doi:10.11603/1681-2727.2023.4.14251
Ganuwa, M. A., Akharenegbe, P., Nsemoh, H. E., Okposhi, I. I., & Orole, O. O. (2024) · Lafia Journal of Scientific and industrial Research · doi:10.62050/ljsir2024.v2n2.306
“Some azoles directly increase the permeability of fungal cell membranes and others hinder the conversion of lanosterol to ergosterol by inhibiting the activity of lanosterol 14α-demethylase [9, 10].”
BackgroundNEW STRATEGIES IN COMBATING FUNGAL PATHOGENS
Hrynzovska, A., & Bobyr, V. V. (2024) · Medical Science of Ukraine (MSU) · doi:10.32345/2664-4738.2.2024.14
Ansari, A., Kumar, D., Rai, N., & Kumar, N. (2024) · Environment Conservation Journal · doi:10.36953/ecj.27762844
“The aforementioned factors are recognized to augment the development of diseases in C. glabrata and are the focus of several widely used antifungal agents (Ivanov et al. , 2022).”
BackgroundButle, S. R., Sharif, S. S., & Deshmukh, M. P. (2024) · Research Square · doi:10.21203/rs.3.rs-4953347/v1
Tuấn, Đ. A. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5069735
Waykar, R. G., & Kumarapillai, S. (2025) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/zm6uc
Kpongbo, E. A., Sébastien, A. J. M., N'guiachi, M. A., Matenin, O., Valérie, A. B.-T., Estelle, M. K., Pulchérie, C. K.-B., Kassi, K. F., Bosson-Vanga, H., Konaté-Touré, A., et al. (2025) · Journal of Yeast and Fungal Research · doi:10.5897/jyfr2024.0216
Antimicrobial Activities of the Bidens Species
Sadaf, H. M. (2025) · Springer eBooks · doi:10.1007/978-981-96-4257-1_13 · Cited by 1
Bioactive Compound as Downregulators of Biofilm-Forming Genes
Hamad, A. M. A., & Tayel, A. (2025) · Springer eBooks · doi:10.1007/978-981-96-4379-0_9
Campos, J. C. P., de Oliveira, D. B. C., Souza, B. D. S., de Oliveira, L. F., de Siqueira, E. P., Kohlhoff, M., & Andrade, A. A. (2025) · Canadian Journal of Microbiology · doi:10.1139/cjm-2025-0009
Chattha, G. M., Chattha, M. A., Beys‐da‐Silva, W. O., & Santi, L. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107125 · Cited by 1
Evidence of use of microalgae in dermatophytosis control
Lage, V. M. G. B., Deegan, K. R., de Sousa, J. S. P., Nader, Y. Á., Barbosa, C. D. J., & Lima, S. T. D. C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22080-7.00008-9
Duy-Pino, D. C., Cuenca-León, K., Bravo, P. P. O., & Lima-Illescas, M. V. (2025) · CIENCIAMATRIA · doi:10.35381/cm.v11i1.1575
Srećković, M. M., Petrović, J. D., Ivanov, M., Gašić, U. M., Milivojević, M., Ninković, D. S., & Stojković, D. S. (2025) · EXCLI journal · doi:10.17179/excli2025-8344 · Cited by 1
Self-citationResistome and Resistance Mechanisms of Candidozyma Auris Clade IV: A Systematic Review
Bonilla-Caballero, M. A., Álvarez, G., & González, Á. F. (2025) · Current Tropical Medicine Reports · doi:10.1007/s40475-025-00353-3
“The analyzed studies showed that Clade IV isolates are resistant to the three groups of antifungals currently used to treat C. auris —azoles, echinocandins and polyenes [1, 30–33].”
Global Burden of Fungal Infections and Medicinal Plant-Based Treatments
Sharma, U., & Singh, T. (2025) · Springer eBooks · doi:10.1007/978-3-032-03604-9_8
Karabuğday (Fagopyrum esculentum Moench.) Kepeğinin Yem Kalitesi
Yavaş, H., Öztürk, S. N., Güneş, A., Azak, M., & GÜLÜMSER, E. (2025) · Türkiye Tarımsal Araştırmalar Dergisi · doi:10.19159/tutad.1727697
Benamar, K., Ezzouggari, R., Dehbi, I., Radi, M., Taoussi, M., Lahlali, R., Koraichi, S. I., & Fikri-Benbrahim, K. (2025) · CABI Reviews · doi:10.1079/cabireviews.2025.0071
Haidu, D., Nicola, R., Rusu, D.-O., Ianăşi, C., Terban, M. W., & Lacrămă, A.-M. (2025) · Preprints.org · doi:10.20944/preprints202511.1697.v1
Antifungal drugs, resistance towards them, and their mechanisms
Sambre, S., Chavan, P., Girse, H., & Gajbhiye, K. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29273-6.00002-3
Waykar, R. G., & Kumarapillai, S. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5093812
The Impact of p.Y91H loss-of-function CARD9 Mutation on Dendritic Cell Antifungal Immunity
Kazimerczak-Brunet, M. (2024) · eScholarship@McGill (McGill) · doi:10.82308/28584
Prado, J. C. S. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Avtonomova, A. V., Валерьевна, К. О., Lysenkova, L. N., & Krasnopolskaya, T. S. (2025) · Antibiot Khimioter = Antibiotics and Chemotherapy · doi:10.37489/0235-2990-2025-70-9-10-62-76
Stress-Activated Protein Kinase Pathways as Potential Targets for the Development of New Antifungals
Alonso‐Monge, R., Guirao-Abad, J. P., & Argüelles, J. C. (2026) · Journal of Fungi · doi:10.3390/jof12020142 · Cited by 1
“Likewise, some side-off gastrointestinal and cardiovascular effects have been reported in treated patients [16].”
Janek, T., Gosecki, M., Urbaniak, M., Wielgus, E., & Gosecka, M. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.03.003
Antifungal drug resistance: Current mechanisms and future directions
Tang, M., Fan, L., Shen, L., & Xing, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36518-8.00009-6
Москалюк, В. Д., Кравчук, И. И., & Randiuk, Y. O. (2026) · Medical Science of Ukraine (MSU) · doi:10.32345/2664-4738.1.2026.02
Sharma, S., Alam, S., & Nagpal, D. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10658-z
“Its mechanism of action involves inhibition of the cytochrome P450-dependent enzyme sterol 14α-demethylase, leading to disruption of ergosterol biosynthesis, a key component of fungal cell membranes [ 8 ].”
Efficacy of Itraconazole in Prevention of Recurrence of Pyriasis Versicolor
Babar, Z., Ahmed, N., Khan, S. A., & Abbas, N. (2025) · Biological and Clinical Sciences Research Journal · doi:10.54112/bcsrj.v6i9.2230
Kidd, J., Sun, C., Garay, A., Keplinger, M., Richter, C., May, A. E., & Liu, Q. (2026) · Protein Science · doi:10.1002/pro.70575
Abbasloo, S., Hashemi, S. M. H., Martinez, F., & Mohammadian, E. (2026) · Journal of Solution Chemistry · doi:10.1007/s10953-026-01570-8
“At higher systemic doses, ketoconazole can also inhibit human CYP3A4 enzymes, potentially affecting the metabolism of medications like cyclosporine, warfarin, and phenytoin, and increasing the risk of drug interactions [3–6].”
Underutilized Plant-Derived Nanoparticles Against Pathogenic Fungi
Ammar, E. E., Ghosh, S., Hassan, I. A. I., Gad, M. E., Ekramy, S., Ibrahim, I. W., & Ibrahim, H. A. M. (2026) · Springer eBooks · doi:10.1007/978-3-032-20384-7_8
Impact of Antifungal Medications on the Health of Pets: A Review
Abdullah, N. K., Al-Najmawi, T. K., abdulhameed, S. K., Alhafidh, N. M., Haddad, M. F., & Saadi, A. M. (2026) · Springer proceedings in earth and environmental sciences · doi:10.1007/978-3-032-18970-7_94
Sesame Oil in the Management of Fungal Infections: From Traditional Remedy to Modern Drug Delivery
Kumari, P., Jawla, D. S., Rohilla, S., Rawal, N., Kundu, L., & Sharma, R. R. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.32s.71
Ćirić, A., Carević, T., Kostić, M., Días, M. I., Barros, L., Ferreira, I. C. F. R., Ninković, D. S., Stojković, D. S., & Ivanov, M. (2026) · Industrial Crops and Products · doi:10.1016/j.indcrop.2026.123546
Self-citationSankar, D. S., Selvam, S. P., Krishnasamy, N., & Pandiar, D. (2026) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.20.2.42
Garg, T., Saini, M., Kumar, A., & MITTAL, D. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.53s.12
Sekily, M. A. E., Mancy, S. H., & Hamada, N. M. M. (2026) · International Journal of Organic Chemistry · doi:10.4236/ijoc.2026.162004
Salve, S., Shende, H., Desai, N., Doh, J., Qureshi, N., Borkar, M. R., Mhapankar, R., Sharbidre, A. A., Kumbhar, V., Khairnar, B., et al. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108676
Design, synthesis, and activity evaluation of novel arylpyrrolidinones NMT antifungal inhibitors
Zhang, A., Zhang, S., Liu, Y., & Sun, B. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110230
Ozanique, P. R., Avesani, J. G. G., & Regasini, L. O. (2026) · Springer eBooks · doi:10.1007/978-3-642-36202-6_246-1
Amin, B. H., Elsharkawy, A. A., Galhom, R. A., Rady, M. H., Aboraya, D. M., Mekky, A. E., Helal, E. E.-H., Abdelsamed, H. A., Yosri, M., & Amer, A. E. (2026) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2026.2705916 · Cited by 1
“…cationic peptides and is considered advantageous in overcoming resistance mechanisms commonly encountered with conventional antifungal drugs [44]. transmission electron microscopy revealed profound ultra-structural damage in C. albicans cells treated with masto-paran, including disruption…”
Searching antifungal agents for invasive fungal infection from natural products
Chou, S. (2026) · Studies in natural products chemistry · doi:10.1016/b978-0-443-49142-9.00007-x
Probiotics Tackling Other Fungal Infections and Intoxications
Preethu, A. H., Shaw, T., Dhoni, S., Hanumantharaju, K. N., & Gurikar, C. (2026) · Springer eBooks · doi:10.1007/978-981-92-0002-3_16
Antifungals: mechanism of action, resistance, and therapeutic perspectives
Gómez-Gaviria, M., & Mora-Montes, H. M. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108771
Dohare, E., Amirthalingam, R., Jadav, M., Dohare, S., Pooja, D., & Kulhari, H. (2026) · Next Materials · doi:10.1016/j.nxmate.2026.103217
Bharti, S., Mukherji, S., & Mukherji, S. (2026) · BioNanoScience · doi:10.1007/s12668-026-02788-y
Mapping antimicrobials in plant lineages
Bitchagno, G. T. M., Coates, P., Garcia, E., Bhatia, S. S., Correia, A., Mulligan, D., Bintrim, S., & Simmonds, M. S. J. (2026) · Frontiers in Plant Science · doi:10.3389/fpls.2026.1936509
Mechanisms of Fungal Pathogenesis and the Role of Surface Proteins in Host Attachment
Patel, T. K. (2026) · IGI Global eBooks · doi:10.4018/979-8-2600-0206-3.ch003
Closing the Gap: Advances and Barriers on Candida Vaccines Development in the Last Decade
Krier, J., Allkja, J., da Costa, A. V., Silva, F. A. M., & Rodrigues, C. F. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198490
Rethinking Candida Vaccine Translation: Barriers, Immunotherapies and a One Health Imperative
Krier, J., Silva, F. A. M., & Rodrigues, C. F. (2026) · Vaccines · doi:10.3390/vaccines14090825
“By blocking the morphological yeast-to-hypha transition and destabilizing the exopolysaccharide matrix of mature Candida biofilms, these molecules render the pathogen significantly more susceptible to host immunological clearance [19].”
Rodrigues, B. B. (2026) · International Journal of Applied Resilience and Sustainability · doi:10.70593/deepsci.0204003
Kłos, M., Janeczko, M., Mickiewicz, B., Kozyra, P., & Kubiński, K. (2026) · Future Medicinal Chemistry · doi:10.1080/17568919.2026.2736311
Ahamed, M. S., Howlader, N. A., Ahamed, A., Islam, M. A., Jahan, R., Nasrin, N., Das, A., Mahmud, S., & Repon, M. R. (2026) · Next research. · doi:10.1016/j.nexres.2026.102564
Metadata
- Authors
- Ivanov, M., Ćirić, A., & Stojković, D.
- Affiliations
- University of Belgrade (RS)
- Corresponding author
- Ivanov, Marija
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-03-02
- Volume
- 23
- Issue
- 5
- Pages
- 2756
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8911111
- OpenAlex
- W4214877855
- Cited by
- 160
- References
- 154
- Citations by year
- 2026: 31 · 2025: 46 · 2024: 36 · 2023: 35 · 2022: 12
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministarstvo prosvete, nauke i tehnoloskog razvoja (451-03-9/2021–14/200007)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- antifungal drug discovery, antifungal drug targets, fungal infection, efflux pumps, HSP90, fungal virulence factors, biofilm, fungal hyphae, fungal enzymes, fungal metabolism, mitochondria, cell wall, antifungal vaccines, plant extracts, natural products, synthetic compounds, drug resistance
- MeSH terms
- Antifungal Agents, Cell Wall, Humans, Mycoses, Biofilms, Drug Resistance, Fungal, Hyphae
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.